Alexander Shtilbans MD, PhD, MS
Neurology
HSS - Belaire Building525 East 71st Street, 5th Floor
New York, NY 10021
Tel: 212.774.7308
Fax: 212.774.2739
New York, NY 10021
Tel: 212.774.7308
Fax: 212.774.2739
About Dr. Alexander Shtilbans
Dr. Alexander Shtilbans is a board certified neurologist whose clinical interest lies in the area of neurodegenerative diseases, particularly Parkinson's disease. He began his career as a molecular biologist in Neuroscience and, after obtaining his PhD, transitioned into clinical Neurology in order to work with patients and gain a better understanding of the clinical course of these diseases.
Dr. Shtilbans received his medical degree from Mount Sinai School of Medicine, where he also completed his residency in Neurology and served as a chief resident. Subsequently, he trained with Dr. Stanley Fahn during his clinical fellowship in Movement Disorders at Columbia University. Dr. Shtilbans has a longstanding interest in translational research and is currently involved in several clinical trials in Parkinson's Disease.
As a physician scientist, Dr. Shtilbans is interested in developing new therapies that will slow down the progression of neurodegenerative diseases. His goal is to better understand molecular mechanisms of the neurodegenerative processes by being actively involved in both clinical and basic science research.
Dr. Shtilbans serves as a co-Principal Investigator on an R01 grant from NIH to develop brain iron mapping techniques and study the role of iron accumulation in pathogenesis of Parkinson's Disease. The obtained knowledge from this clinical trial would help in future clinical trials aimed to determine if chelation of brain iron in Parkinson’s disease patients produces clinical benefit due to disease modifying effects.
He has been publishing his research findings and has received multiple awards from the American Academy of Neurology.
Profile Video
Departments
Special Expertise
Movement Disorders: Parkinson's disease, Tremor, dystonia, myoclonus, restless leg syndrome, tardive dyskinesia
Procedures
Botox injections for cervical dysdonia, blepharospasms, hemifacial spasms, spasticity.
Deep brain stimulation (DBS) programming and adjustments.
Patient Stories
Videos
Insurance
Aetna
BCBS Anthem Gatekeeper Individual Network
BCBS Federal
BCBS Anthem of NY (formerly Empire)
BCBS Horizon (excluding OMNIA)
Cigna
Connecticare (not through Access Health CT)
EmblemHealth GHI
EmblemHealth HIP
EmblemHealth Medicare
EmblemHealth Select Care
The Empire Plan / NYSHIP
Medicare Part B
Oxford
UnitedHealthcare
UnitedHealthcare Compass
UnitedHealthcare Medicare HMO
UnitedHealthcare Medicare PPO
BCBS Anthem Gatekeeper Individual Network
BCBS Federal
BCBS Anthem of NY (formerly Empire)
BCBS Horizon (excluding OMNIA)
Cigna
Connecticare (not through Access Health CT)
EmblemHealth GHI
EmblemHealth HIP
EmblemHealth Medicare
EmblemHealth Select Care
The Empire Plan / NYSHIP
Medicare Part B
Oxford
UnitedHealthcare
UnitedHealthcare Compass
UnitedHealthcare Medicare HMO
UnitedHealthcare Medicare PPO
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Credentials
Appointments
Assistant Attending, Hospital for Special Surgery
Assistant Professor, Weill Medical College of Cornell University
Affiliations
American Academy of Neurology
Movement Disorders Society
Certification
American Board of Psychiatry and Neurology (Neurology), 2010
Awards
Medical Student Prize for Excellence in Neurology, American Academy of Neurology (2006)
Extended Neuroscience Award, American Academy of Neurology (2006)
Medical Student Essay: Novel pathogenic mutations in human mitochondrial DNA genes
Education
Doctor of Medicine, Mount Sinai School of Medicine, New York, NY, 2006
Ph.D., Biological Sciences, St. Petersburg Technological Institute, St. Petersburg, Russia, 2002
Masters, Biology, New York University, Graduate School of Arts and Science, New York, NY, 1997
Internship: Internal Medicine, St. Luke's Roosevelt Hospital Center, New York, NY, 2007
Residency: Neurology, Mount Sinai Medical Center, New York, NY, 2010
Fellowship: Movement Disorders, Columbia University Medical Center, New York, NY 2011
State Licensure
New York, New Jersey
Languages
English, Russian
For My Patients
New Patient Forms (pdf)
Publications by Dr. Alexander Shtilbans
Selected Journal Articles
Shtilbans A, Choi S, Fowkes M, Khitrov G, Shahbazi M, Ting J, Zhang W, Sun Y, Sealfon S, Lange D. Differential gene expression in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler, 2011; 12(4):250-6.
Shtilbans A, Shanske S, Goodman S, Sue C, Bruno C, Johnson T, Lava N, Waheed N, DiMauro S. G8363A mutation in the mtDNA tRNALys gene: another cause of Leigh syndrome.
J Child Neurol, 2000; 15(11):759-761.
Shtilbans A, El-Schahawi M, Malkin E, Shanske S, Musumeci O, DiMauro S.
A novel mutation in the mitochondrial DNA transfer ribonucleic acid Asp gene in a child with myoclonic epilepsy and psychomotor regression. J Child Neurol, 1999; 14:610-613.
Andreu AL, Bruno C, Dunne TC, Tanji K, Shanske S, Sue CM, Krishna S, Hadjigeorgiou GM, Shtilbans A, Bonilla E, DiMauro S. A nonsense mutation (G15059A) in the cytochrome b gene in a patient with exercise intolerance and myoglobinuria. Ann Neurol, 1999; 45(1):127-130.
Andreu AL, Bruno C, Shanske S, Shtilbans A, Hirano M, Krishna S, Hayward L, Systrom DS, Brown RH Jr, DiMauro S. Missense mutation in the mtDNA cytochrome b gene in a patient with myopathy. Neurology, 1998; 51(5):1444-1447.
Kirov N, Shtilbans A, Rushlow C. Isolation and characterization of a new gene encoding a member of the HIRA family of proteins from Drosophila melanogaster. Gene, 1998; 212(2):323-332.
Hirano M, Shtilbans A, Mayeux R, Davidson MM, DiMauro S, Knowles JA, Schon EA.
Apparent mtDNA heteroplasmy in Alzheimer’s Disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes. Proc Natl Acad Sci USA, 1997; 94:14894-14899.
Research
Research Interests
Study of genetic biomarkers and novel treatments for Neurodegenerative diseases including Parkinson's disease and ALS.
Industry Relationships
Industry Relationships
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
Below are the healthcare industry relationships reported by Dr. Shtilbans as of June 06, 2024.
- Amneal Pharmaceuticals – Speakers' Bureau
- Kyowa Kirin – Speakers' Bureau
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.
